Whilst there is little information on its anti-tumour immunomodulatory effects, studies have shown that C3G reduced rheumatoid arthritis presentation, and concurrently increased IL-10, Tregs, and decreased IL-6, IFN-γ and NK cell activity [202]. This evidence concerns the gene IL10 and neoplasm.